Ciprofloxacin
소아

소아

IV Form

Safety and efficacy in pediatric patients <18y of age have not been established

Ciprofloxacin should be used as an alternative option for complicated UTI in pediatric patients aged 1-17y and for inhalation anthrax PEP

Complicated UTI

6-10 mg/kg IV q8h x10-21d (max 400 mg/dose)

Inhalation anthrax PEP

10 mg/kg IV q12h x60d (max 400 mg/dose)

Oral Form

Complicated UTI

10-20 mg/kg PO q12h x10-21d (max 750 mg/dose)

Inhalation anthrax PEP

15 mg/kg PO q12h x60d (max 500 mg/dose)